Purchase Order 12805B21P0141

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...

This is a $80,000 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to GenScript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for customized protein production services, including expression construct preparation, expression and purification, and quality control tests. This is a sole-source award, as NIH has invested in a proprietary...

This federal contract award is for NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENVELOPE TRIMER PROTEINS, with a ceiling value of $3,816,780.25. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods specializing in the development of vaccines, therapeutics, and diagnostics. The contract is a delivery order under the NIAID PRECLINICAL DEVELOPMENT SUPPORT - PERFORMANCE OF TOXICITY TESTING FOR HIV PROTEINS...

This federal contract award, valued at $11,720.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to EMD Millipore Corporation, a foreign-owned, for-profit manufacturer of laboratory products and services. The contract is for the supply of 5 kg of PROBUMIN, a protein purification product, and has a firm fixed price structure. The award does not include a set-aside designation. EMD Millipore Corporation provides a wide range of filtration, purification, and cell...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide custom-produced biotinylated and non-biotinylated proteins. The $45,035.54 contract supports the mission of the Vaccine Research Center, which had previously used Genscript's proteins in downstream experiments. The contract has no set-aside designation. Genscript, based in Piscataway,...

This is a firm fixed price purchase order contract awarded by the Department of Agriculture's Agricultural Research Service to Proteogenix, a for-profit biotechnology manufacturer, for the custom acquisition of baculoviruses expressing proteins from the African Swine Fever Virus (ASFV). The $240,000 contract was awarded on September 22, 2020 with a completion date of September 29, 2021. The contract did not have a set-aside designation, indicating that it was competed in full and open...

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $14,090 contract is for custom protein production services to support biomedical research and public health initiatives. The award is not associated with a larger contract vehicle and does not have a set-aside designation....

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Proteos Inc., a small business contractor. The contract is for the custom expression and purification of an HIV protein called OTSB, with a ceiling value of $11,069.00. Proteos Inc. has demonstrated expertise in producing high-quality recombinant proteins, particularly HIV-related proteins, which are crucial for research...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of HIV-1gp120 protein in support of NIAID's preclinical development program. The contract, which does not have a set-aside designation, has a ceiling value of $4,240,924.91 and an ultimate...

This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $17,241,407.00 task order supports good manufacturing practice (cGMP) manufacturing of the PGT121.414.LS monoclonal antibody (PGT121.414.LS mAb) drug substance, complete fill-finish of the drug substance into drug product, and...